Healthways to provide health, wellness services to Family Dollar team members
MATTHEWS, N.C. — Family Dollar has inked a partnership with a national leader in health-and-wellness solutions to further drive the retailer’s commitment to proactively engage in activities that encourage healthy living.
Family Dollar said its multiyear agreement with Healthways offers the retailer’s team members a range of wellness programs to optimize their health. As part of the agreement, Family Dollar is offering its estimated 50,000 full-time and part-time team members a variety of integrated services, collectively known as the Healthways Well-Being Improvement Solution. Some of these services will include Healthways Well-Being assessments, the Well-Being Connect Web-based personal behavior change application, WellbeingGo mobile application, biometric screenings, on-site program management and engagement marketing, health risk coaching, incentive management and wellness competitions and challenges. Healthways assumed responsibility for program management and delivery of services as of Oct. 1.
"We are proud to offer this new program to our team members because fostering opportunities to enhance well-being is crucial to developing a healthy corporate culture and highlights our drive to be a compelling place to work," Family Dollar CEO Howard Levine said. "We are pleased that, through our partnership with Healthways, our team members will have access to transformational technologies and services that are shaping a new age of healthy living."
No comments found
Costco experiences net, same-store sales jump for September
NEW YORK — Costco Wholesale reported a better-than-expected 6% rise in September same-store sales, helped by higher gasoline prices and a stronger dollar.
Excluding the impact of gasoline prices and foreign exchange, comparable same-store sales rose 5% for the month.
Net sales rose 8% to $9.31 billion in the five weeks ended Sept. 30. Costco, which currently operates 608 warehouses, said it plans to open up to 14 new warehouses prior to the end of calendar year 2012.
No comments found
Study: Hypercholesterolemia patients adherent to medication regimen may be healthier, but at a price
ST. PAUL, Minn. — Patients with high cholesterol who take statins may be healthier than those who do not, but their overall healthcare costs may be slightly higher than their counterparts, according to a new study.
The study, conducted by pharmacy benefit manager Prime Therapeutics in collaboration with Blue Cross and Blue Shield of Minnesota, found that while hypercholesterolemia patients adherent to statin medication went to the hospital or emergency department 2.6% less often than nonadherent individuals — resulting in medical costs that were 7% lower (a difference of $767) — the lower medical costs were offset by pharmacy costs that were 45% higher (a difference of $1,606). In the study, researchers from Prime and Blue Cross compared medical and pharmacy costs among individuals with high cholesterol who were adherent to their statin medication to individuals who were not adherent ("adherence" was defined as following the medication regime 80% of the time or more). Of the 45,869 members included in the study, 21,693 (47.3%) were adherent and 24,176 (52.7%) nonadherent during the two-year follow-up period.
The study results were presented at the Academy of Managed Care Pharmacy’s 2012 Educational Conference.
"This study is a continuation of our collaborative work with Blue Cross into understanding the connection between adherence and total cost of health care, including hospitalizations," said Pat Gleason, director of clinical outcomes assessment with Prime. "With the increasing availability of generic statins, especially the generic atorvastatin of the brand Lipitor, the higher pharmacy costs we found may be lowered. In this study, adherence to statins was associated with lower medical costs and hospitalizations, two very important outcomes that will help up us recommend solutions that lead to healthier outcomes for individuals."
To view the full results of the study, click here.
I'm not surprised by the study results, I would have been surprised if those who stick to their treatments were in worse health that the others. When it comes to such devastating conditions I think it's essential to for the patients to be adherent to their treatment.
A LARGE study should also be conducted to look at the symptoms from taking Satins long term. The worse thus far is memory loss. A great many patients also suffer from muscle and joint pain with little knowledge as to the why and most physicians want their patients to continue on with the stains because of the industry profits as opposed to the good test results. A better understanding of the true, long and short term effects of these drugs needs to be investigated. I doubt unfortunately this will happen for the reason stated above and that is a medical shame. There are small studies out there, yet the public is not informed. Sometimes, bigger is better...